Kenya has been granted a licence to manufacture a new monthly HIV prevention pill for African markets, making it one of three countries on the continent set to produce the drug. The move marks the first time African manufacturers have been included in the licensing of an HIV medicine from the beginning. Pharmaceutical company Merck